ECT: AN INNOVATIVE TUMOR TREATMENT
Electrochemotherapy (ECT) is a relatively new treatment that has been proven to show a complete response in the elimination of tumors in companion animals.
RXVET TK-1: AN EASY-TO-USE ECT DEVICE
Portable and affordable, the RXVET TK-1 is now available in the US for the effective treatment of tumors as a part of adjuvant, neoadjuvant, or palliative care in horses, dogs, and cats.
WHY USE ECT: SEE WHAT VETS ARE SAYING
Numerous studies have proven both the efficacy and safety of electrochemotherapy in the treatment of cancerous tumors in equine, feline, and canine subjects in the US and abroad.
Companion Animals
The incidence of cutaneous and subcutaneous cancerous tumors in companion animals has steadily grown over the years, which can lead to shortened lifespans and a reduced quality of life. Treatment of these tumors has traditionally been limited to surgery, chemotherapy, radiation, or a combination of these options.
However, due to location or growth patterns, some tumors cannot be treated by these methods. Electrochemotherapy (ECT) is a safe and effective alternative to these traditional methods that does not involve surgery and in many instances works with a single treatment
RXVET TK-1
A New Way to Treat Tumors
- Easy-to-use ECT device designed specifically for veterinary care
- Treats many types of tumors in horses, dogs, and cats
- Allows for the enhanced delivery of chemotherapy and increased drug absorption
- Proven efficacy with high success rates and low reoccurrence rates
- No or minimal systemic side effects
- Can be repeated with equal or improved efficacy
- Covered by many pet health insurance companies as a cancer treatment
PORTABLE, AFFORDABLE
AND EFFECTIVE
RXVET Biotech is the only US based distributor of RXVET TK-1, an ECT device that has proven efficacy, is safe for animals, is easy-to-use, and does not need special training to operate.
97.9
Complete response rate in sarcoid tumors after 4 years in horses
87.5
Objective response rate in squamous cell carcinoma after 3 years in cats
62.5
Complete response rate in mast cell tumors* after 3 years in dogs
What the Experts
are Saying
"Electrochemotherapy has revolutionized the way I treat many superficial tumors both after surgery as a “clean-up” or in lieu of surgery. As a board certified Medical Oncologist in private practice, I see a variety of cancers on a daily basis. I have worked with ECT since 2010 in the United States having been trained in Europe. I have been very pleased with its application in many tumor types. A comfort level with the safety and handling of the chemotherapy is also imperative. The RXVet is easy to use and has many applications with the small needle and caliper array probes. I highly recommend this product as another tool to help your cancer patients."
Chelsea Tripp, DVM, MS, DACVIM (O) – Seattle, WA
"I am using it for cutaneous SCC (in situ) with much better success than any other way I have used."
Gary Norsworthy
HAVE
QUESTIONS?
- Contact our customer support team if you have any questions.